v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2024
Operating activities:      
Net earnings $ 601 $ 824 $ 292
Adjustments to reconcile net earnings to net cash provided by operations:      
Depreciation and amortization 247 219 235
Stock-based compensation 48 81 74
Deferred income taxes 81 (18) (100)
Venture agreement payment 476 0 0
Loss on divestiture 0 112 238
Pension settlement charge 0 0 171
Other (7) (26) 26
Changes in:      
Receivables, net 151 (145) (34)
Inventories, net (71) 63 55
Prepaid expenses and other current assets 2 (9) 25
Accounts payable and accrued liabilities 38 (124) (140)
Operating lease right-of-use assets and liabilities, net (4) 2 0
Income taxes payable/prepaid 2 2 (147)
Net cash provided by operations 612 981 695
Investing activities:      
Capital expenditures (207) (220) (212)
Business acquired, net of cash acquired (2,104) 0 0
Proceeds from divestiture, net of cash divested 0 128 17
Other 10 (2) 20
Net cash used for investing activities (2,301) (94) (175)
Financing activities:      
Notes and loans payable, net 1,078 0 (45)
Debt borrowings, net of issuance costs paid 2,737 0 0
Debt repayments (1,250) 0 0
Treasury stock purchased (256) (332) 0
Cash dividends paid to Clorox stockholders (602) (602) (595)
Cash dividends paid to noncontrolling interests (16) (16) (16)
Issuance of common stock for employee stock plans and other (23) 26 1
Net cash provided by (used for) financing activities 1,668 (924) (655)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (2) 0 (26)
Net increase (decrease) in cash, cash equivalents and restricted cash (23) (37) (161)
Cash, cash equivalents and restricted cash:      
Beginning of year 170 207 368
End of year 147 170 207
Supplemental cash flow information:      
Interest paid 122 97 102
Income taxes paid, net of refunds 104 264 347
Noncash financing activities:      
Cash dividends declared and accrued, but not paid $ 16 $ 16 $ 16